A Kaplan-Meier analysis showed that there was no significant difference between the low- and high-risk groups in IDH-mutant GBM from the CGGA-RNAseq and TCGA-microarray datasets (Figures S1A,B). This evidence concerns the gene IDH1 and glioblastoma.